Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT ID: NCT01361386
Last Updated: 2014-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13011 participants
OBSERVATIONAL
2011-06-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
NCT02305680
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531
Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients
NCT04861363
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
NCT03051061
The Prevention of Thromboembolic Complications Associated With Coil Embolization
NCT05512546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of STEMI, NSTEMI or UA
* Hospitalization for the first time within 48 hours of onset of symptoms.
Exclusion Criteria
* Current participation in a randomised interventional clinical trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guy Yeoman
Role: STUDY_DIRECTOR
AstraZeneca
Prof. Huo Yong
Role: STUDY_CHAIR
Peking University 1st Hospital
Jayanti Visvanathan
Role: STUDY_CHAIR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Hefei, Anhui, China
Research Site
Wuhu, Anhui, China
Research Site
Beijing, Beijing Municipality, China
Research Site
Chongqing, Chongqing Municipality, China
Research Site
Fuzhou, Fujian, China
Research Site
Lanzhou, Gansu, China
Research Site
Foshan, Guangdong, China
Research Site
Guangzhou, Guangdong, China
Research Site
Shenzhen, Guangdong, China
Research Site
Nanning, Guangxi, China
Research Site
Yulin, Guangxi, China
Research Site
Guiyang, Guizhou, China
Research Site
Baoding, Hebei, China
Research Site
Shijiazhuang, Hebei, China
Research Site
Tangshan, Hebei, China
Research Site
Daqing, Heilongjiang, China
Research Site
Harbin, Heilongjiang, China
Research Site
Zhengzhou, Henan, China
Research Site
Shiyan, Hubei, China
Research Site
Wuhan, Hubei, China
Research Site
Changsha, Hunan, China
Research Site
Nanjing, Jiangsu, China
Research Site
Wuxi, Jiangsu, China
Research Site
Xuzhou, Jiangsu, China
Research Site
Zhenjiang, Jiangsu, China
Research Site
Changchun, Jilin, China
Research Site
Jinzhou, Liaoning, China
Research Site
Shenyang, Liaoning, China
Research Site
Yingkou, Liaoning, China
Research Site
Xining, Qinghai, China
Research Site
Xi'an, Shaanxi, China
Research Site
Jinan, Shandong, China
Research Site
Shanghai, Shanghai Municipality, China
Research Site
Changzhi, Shanxi, China
Research Site
Jinzhong, Shanxi, China
Research Site
Taiyuan, Shanxi, China
Research Site
Chengdu, Sichuan, China
Research Site
Tianjin, Tianjin Municipality, China
Research Site
Shihezi, Xinjiang, China
Research Site
Urumuqi, Xinjiang, China
Research Site
Kunming, Yunnan, China
Research Site
Hangzhou, Zhejiang, China
Research Site
Hong Kong, , China
Research Site
Ningxia, , China
Research Site
Qingdao, , China
Research Site
Hyderabad, Andhra Pradesh, India
Research Site
Guwahati, Assam, India
Research Site
Ahmedabad, Gujarat, India
Research Site
Surat, Gujarat, India
Research Site
Vadodara, Gujarat, India
Research Site
Gurgaon, Haryana, India
Research Site
Bangalore, Karnataka, India
Research Site
Manipal, Karnataka, India
Research Site
Kochi, Kerala, India
Research Site
Trivandrum, Kerala, India
Research Site
Bhopal, Madhya Pradesh, India
Research Site
Bilāspur, Madhya Pradesh, India
Research Site
Aurangabad, Maharashtra, India
Research Site
Mumbai, Maharashtra, India
Research Site
Nagpur, Maharashtra, India
Research Site
Pune, Maharashtra, India
Research Site
Delhi, National Capital Territory of Delhi, India
Research Site
Ludhiana, Punjab, India
Research Site
Mohali, Punjab, India
Research Site
Ajmer, Rajasthan, India
Research Site
Jaipur, Rajasthan, India
Research Site
Chennai, Tamil Nadu, India
Research Site
Coimbatore, Tamil Nadu, India
Research Site
Madurai, Tamil Nadu, India
Research Site
Lucknow, Uttar Pradesh, India
Research Site
Kolkata, West Bengal, India
Research Site
Sarawak, Kuching, Malaysia
Research Site
George Town, , Malaysia
Research Site
Singapore, , Singapore
Research Site
Busan, Busan, South Korea
Research Site
Chuncheon, Chuncheon, South Korea
Research Site
Cheonan, Chungcheongnam-do, South Korea
Research Site
Deagu, Deagu, South Korea
Research Site
Gwangju, Gwangju, South Korea
Research Site
Bucheon-si, Gyeonggi-do, South Korea
Research Site
Goyang-si, Gyeonggi-do, South Korea
Research Site
Suwon, Gyeonggi-do, South Korea
Research Site
Yangsan, Gyeongsangnam-do, South Korea
Research Site
Jeju City, Jeju-do, South Korea
Research Site
Iksan, Jeollabuk-do, South Korea
Research Site
Seoul, Seoul, South Korea
Research Site
Bangkoknoi, Bangkok, Thailand
Research Site
Huaykwang, Bangkok, Thailand
Research Site
PathumWan, Bangkok, Thailand
Research Site
Payathai, Bangkok, Thailand
Research Site
Rachathevi, Bangkok, Thailand
Research Site
Saimai, Bangkok, Thailand
Research Site
Muang, Changwat Chanthaburi, Thailand
Research Site
Muang, Changwat Chon Buri, Thailand
Research Site
Muang, Changwat Lampang, Thailand
Research Site
Muang, Changwat Nan, Thailand
Research Site
Klongluang, Changwat Pathum Thani, Thailand
Research Site
Muang, Changwat Phitsanulok, Thailand
Research Site
Muang, Changwat Songkhla, Thailand
Research Site
Muang, Changwat Suphan Buri, Thailand
Research Site
Muang, Changwat Surat Thani, Thailand
Research Site
Muang, Chiangmai, Thailand
Research Site
Muang, Chiangrai, Thailand
Research Site
Muang, Khonkaen, Thailand
Research Site
Muang, Nakornratchaseema, Thailand
Research Site
Muang, Udonthani, Thailand
Research Site
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Research Site
Huế, Hue, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Huo Y, Van de Werf F, Han Y, Rossello X, Pocock SJ, Chin CT, Lee SW, Li Y, Jiang J, Vega AM, Medina J, Bueno H. Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia. Am J Cardiovasc Drugs. 2021 Jul;21(4):471-482. doi: 10.1007/s40256-020-00447-5. Epub 2021 Feb 4.
Guan S, Xu X, Li Y, Li J, Guan M, Wang X, Jing Q, Huo Y, Han Y. Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study. J Am Heart Assoc. 2020 Nov 17;9(22):e013476. doi: 10.1161/JAHA.119.013476. Epub 2020 Nov 7.
Zhang S, Wang W, Sawhney JPS, Krittayaphong R, Kim HS, Nhan VT, Lee SW, Ong TK, Chin CT, Pocock SJ, Huo Y, Qian J, Ge J. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. Int J Cardiol. 2020 Jul 1;310:16-22. doi: 10.1016/j.ijcard.2020.01.008. Epub 2020 Mar 17.
Jan S, Lee SW, Sawhney JPS, Ong TK, Chin CT, Kim HS, Krittayaphong R, Nhan VT, Pocock SJ, Vega AM, Hayashi N, Huo Y. Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia. BMC Cardiovasc Disord. 2018 Jul 4;18(1):139. doi: 10.1186/s12872-018-0859-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CAP-XXX-2011/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.